Compounds > adenosine monophosphate
Page last updated: 2024-08-17

adenosine monophosphate and thromboplastin

adenosine monophosphate has been researched along with thromboplastin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chumakov, VN; Starchik, TG1
Kubisz, P; Suranová, J1
Adachi, Y; Gabazza, EC; Hayashi, T; Ido, M; Suzuki, K1
Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L1
FERGUSON, HJ; IATRIDIS, PG1
Feijge, MA; Giesen, PL; Heemskerk, JW; Jerling, JC; Kloots, W; Kuijpers, MJ; Nieuwenhuys, CM; oude Egbrink, MG1

Other Studies

6 other study(ies) available for adenosine monophosphate and thromboplastin

ArticleYear
[Effect of nucleotide anti-aggregants (NAD, AMP) and ischemia on the tissue blood coagulation factors].
    Gematologiia i transfuziologiia, 1991, Volume: 36, Issue:4

    Topics: Adenosine Monophosphate; Animals; Blood Coagulation; Disease Models, Animal; Ischemia; Kidney; Male; NAD; Platelet Aggregation Inhibitors; Rabbits; Rats; Thromboplastin

1991
On the mechanism by which bovine fibrinogen induces the release and availability reaction of human blood platelets.
    Thrombosis et diathesis haemorrhagica, 1973, May-10, Volume: 29, Issue:2

    Topics: Acid Phosphatase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Coagulation; Blood Platelets; Calcium; Cattle; Cell Membrane; Edetic Acid; Fibrinogen; Humans; Platelet Adhesiveness; Thromboplastin; Time Factors

1973
Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism.
    Clinical science (London, England : 1979), 2002, Volume: 102, Issue:2

    Topics: Adenosine; Adenosine Monophosphate; Arginine; Blotting, Northern; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Guanosine Monophosphate; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphodiesterase Inhibitors; Thrombin; Thromboplastin

2002
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions.
    Current medical research and opinion, 2003, Volume: 19, Issue:3

    Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin

2003
INHIBITION OF ENZYMIC (THROMBOKINASE) ACTIVATION OF BLOOD CLOTTING BY ORGANIC PHOSPHATES (ATP, ADP, AMP), INVOLVING A CALCIUM COMPLEX.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1965, Volume: 118

    Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Blood Coagulation; Buffers; Calcium; Calcium, Dietary; Factor Xa; Hydrogen-Ion Concentration; Organophosphates; Research; Thrombin; Thromboplastin

1965
Regulation of tissue factor-induced coagulation and platelet aggregation in flowing whole blood.
    Thrombosis and haemostasis, 2005, Volume: 93, Issue:1

    Topics: Adenosine Monophosphate; Alprostadil; Animals; Blood Coagulation; Disease Models, Animal; Drug Interactions; Fibrin; Fibrinogen; Fibrinolytic Agents; Male; Perfusion; Phosphatidylserines; Platelet Activation; Platelet Aggregation; Rats; Rats, Wistar; Thrombin; Thromboplastin

2005